(Q36335833)

13 August 2017

1 reference

title

The pharmacology of diabetic neuropathy (English)

1 reference

13 August 2017

1 reference

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

18 October 2022

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

18 October 2022

author name string

D. R. Tomlinson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1633740

18 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1633740

18 October 2022

publication date

1 April 1992

1 reference

full work available at URL

13 August 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fdmr.5610080107

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

http://onlinelibrary.wiley.com/wol1/doi/10.1002/dmr.5610080107/fullpdf

18 October 2022

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Diabetes/metabolism reviews

18 October 2022

published in

1 reference

13 August 2017

volume

8

1 reference

13 August 2017

issue

1

1 reference

13 August 2017

page(s)

67-84

1 reference

Diabetic neuropathy: Influence of age, sex, metabolic control, and duration of diabetes on motor conduction velocity

13 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

A study of the peripheral nerves in diabetic subjects during ischaemia

18 October 2022

2

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Variations in motor conduction velocity produced by acute changes of the metabolic state in diabetic patients

18 October 2022

3

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Effects of one year of near-normoglycemia on peripheral nerve function in type 1 (insulin-dependent) diabetic patients

18 October 2022

4

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Axonal transport of cholinergic transmitter enzymes in vagus and sciatic nerves of rats with acute experimental diabetes mellitus; correlation with motor nerve conduction velocity and effects of insulin

18 October 2022

5

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

The effect of aldose reductase inhibition on the pattern of nerve conduction deficits in diabetic rats

18 October 2022

6

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Effects of insulin and dietary myoinositol on impaired peripheral motor nerve conduction velocity in acute streptozotocin diabetes

18 October 2022

7

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

A quantitative comparison of motor and sensory conduction velocities in short- and long-term streptozotocin- and alloxan-diabetic rats

18 October 2022

8

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

The spontaneously diabetic BB Wistar rat. Morphologic and physiologic studies of peripheral nerve

18 October 2022

9

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Nerve Na+-K+-ATPase, conduction, and myo-inositol in the insulin-deficient BB rat

18 October 2022

10

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

The effects of hypoxia on the excitability of the isolated peripheral nerves of alloxan-diabetic rats

18 October 2022

11

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Effect of hyperbaric oxygenation on normal and chronic streptozotocin diabetic peripheral nerves

18 October 2022

12

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Resistance to ischemic conduction block of the peripheral nerve in hyperglycemic rats: an electrophysiological study.

18 October 2022

13

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Effect of aldose reductase inhibition on nerve conduction velocity and resistance to ischemic conduction block in experimental diabetes

18 October 2022

14

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Resistance to hypoxic conduction block in sciatic nerves of rats with streptozotocin-induced diabetes mellitus

18 October 2022

15

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Acute changes in blood glucose affect resistance to ischemic nerve conduction failure

18 October 2022

16

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Central hypoxaemia in rats provokes neurological defects similar to those seen in experimental diabetes mellitus: Evidence for a partial role of endoneurial hypoxia in diabetic neuropathy

18 October 2022

18

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Endoneurial blood flow and oxygen tension in the sciatic nerves of rats with experimental diabetic neuropathy

18 October 2022

19

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Altered blood rheology in the pathogenesis of diabetic and other neuropathies

18 October 2022

21

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Effects of high glucose and sorbitol pathway on lipid peroxidation of erythrocytes

18 October 2022

22

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Study on relationship between erythrocyte filtration and other risk factors in diabetic angiopathy

18 October 2022

23

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Role of red cell sorbitol as determinant of reduced erythrocyte filtrability in insulin-dependent diabetics

18 October 2022

24

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Red cell sorbitol levels during hyper and hypoglycaemic clamp studies in insulin-dependent diabetic patients

18 October 2022

25

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Sorbinil partially prevents decreased erythrocyte deformability in experimental diabetes mellitus

18 October 2022

26

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Effect of statil (ICI 128436) on erythrocyte viscosity in vitro

18 October 2022

27

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Effects of hyperglycaemia and sorbitol accumulation on erythrocyte deformability in diabetes mellitus

18 October 2022

28

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Red-cell aggregation and red-cell deformability in diabetes

18 October 2022

29

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Relationship of endoneurial capillary abnormalities to type and severity of diabetic polyneuropathy

18 October 2022

33

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Effects of Chronic α-Adrenergic Receptor Blockade on Peripheral Nerve Conduction, Hypoxic Resistance, Polyols, Na+-K+-ATPase Activity, and Vascular Supply in STZ-D Rats

18 October 2022

34

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Angiotensin converting enzyme inhibition prevents development of muscle and nerve dysfunction and stimulates angiogenesis in streptozotocin-diabetic rats

18 October 2022

35

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Sorbitol Pathway: Presence in Nerve and Cord with Substrate Accumulation in Diabetes

18 October 2022

36

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Inositol changes in nerve and lens of galactose fed rats

18 October 2022

38

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Reversal, by treatment with an aldose reductase inhibitor, of impaired axonal transport and motor nerve conduction velocity in experimental diabetes mellitus

18 October 2022

39

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Polyol pathway activity and myo-inositol metabolism. A suggested relationship in the pathogenesis of diabetic neuropathy

18 October 2022

40

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Sorbitol, inositol and nerve conduction in diabetes

18 October 2022

41

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Prevention of defects of axonal transport and nerve conduction velocity by oral administration of myo-inositol or an aldose reductase inhibitor in streptozotocin-diabetic rats

18 October 2022

42

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Significance of Tissue myo -Inositol Concentrations in Metabolic Regulation in Nerve

18 October 2022

43

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Has one diabetic complication been explained?

18 October 2022

44

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Protein kinase C agonists acutely normalize decreased ouabain-inhibitable respiration in diabetic rabbit nerve. Implications for (Na,K)-ATPase regulation and diabetic complications

18 October 2022

45

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Impaired rat sciatic nerve sodium-potassium adenosine triphosphatase in acute streptozocin diabetes and its correction by dietary myo-inositol supplementation

18 October 2022

46

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Axo-glial dysjunction. A novel structural lesion that accounts for poorly reversible slowing of nerve conduction in the spontaneously diabetic bio-breeding rat

18 October 2022

47

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Role of sorbitol accumulation and myo-inositol depletion in paranodal swelling of large myelinated nerve fibers in the insulin-deficient spontaneously diabetic bio-breeding rat. Reversal by insulin replacement, an aldose reductase inhibitor, and myo

18 October 2022

48

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Altered sorbitol and myo-inositol metabolism as the basis for defective protein kinase C and (Na,K)-ATPase regulation in diabetic neuropathy

18 October 2022

49

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Banting lecture 1986. Does a common mechanism induce the diverse complications of diabetes?

18 October 2022

50

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

18 October 2022

Diabetic neuropathy

53

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Effect of prostaglandin E1 analogue TFC 612 on diabetic neuropathy in streptozocin-induced diabetic rats. Comparison with aldose reductase inhibitor ONO 2235.

18 October 2022

54

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

SCHWANN-CELL ABNORMALITIES IN DIABETIC NEUROPATHY

18 October 2022

55

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Peripheral nerve structure and function in experimental diabetes

18 October 2022

57

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Distal symmetric polyneuropathy in the spontaneously diabetic BB-wistar rat. An ultrastructural and teased fiber study

18 October 2022

58

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

The development and structural characterization of the neuropathies in the spontaneously diabetic BB Wistar rat

18 October 2022

59

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Hirano-bodies in the distal symmetric polyneuropathy of the spontaneously diabetic BB-Wistar rat

18 October 2022

60

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Studies on peripheral nerve and lens in long-term experimental diabetes: effects of the aldose reductase inhibitor statil

18 October 2022

61

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Pathology and time relationship of peripheral nerve changes in experimental diabetes

18 October 2022

62

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Changes in peripheral nerves of rats four months after induction of streptozotocin diabetes. A qualitative and quantitative study

18 October 2022

64

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Neuropathy and myopathy in the diaphragm of rats after 12 months of streptozotocin-induced diabetes mellitus. A light-, electron-microscopic, and morphometric study

18 October 2022

65

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Ultrastructural abnormalities of myelinated fibres in the tibial nerve of streptozotocin-diabetic rats

18 October 2022

66

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Impaired nerve regeneration in streptozotocin-diabetic rats. Effects of treatment with an aldose reductase inhibitor

18 October 2022

67

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Impaired nerve regeneration in streptozotocin-diabetic rats is improved by treatment with gangliosides

18 October 2022

68

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Defects of axonal transport in diabetes mellitus--a possible contribution to the aetiology of diabetic neuropathy

18 October 2022

70

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Axonal transport and tissue contents of substance P in rats with long-term streptozotocin-diabetes. Effects of the aldose reductase inhibitor 'statil'.

18 October 2022

71

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Deficient axonal transport of substance P in streptozocin-induced diabetic rats. Effects of sorbinil and insulin

18 October 2022

72

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Nerve growth factor (NGF) regulates adult rat cultured dorsal root ganglion neuron responses to the excitotoxin capsaicin

18 October 2022

75

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Nerve growth factor regulates expression of neuropeptide genes in adult sensory neurons

18 October 2022

76

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Endogenous levels of nerve growth factor (NGF) are altered in experimental diabetes mellitus: a possible role for NGF in the pathogenesis of diabetic neuropathy

18 October 2022

77

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Altered axonal transport of cytoskeletal proteins in the mutant diabetic mouse

18 October 2022

78

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Experimental diabetic neuropathy: impairment of slow transport with changes in axon cross-sectional area

18 October 2022

79

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Experimental diabetic neuropathy: similar changes of slow axonal transport and axonal size in different animal models

18 October 2022

80

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Slow axonal transport impairment of cytoskeletal proteins in streptozocin-induced diabetic neuropathy

18 October 2022

81

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Proteins of slow axonal transport in sciatic motoneurones of rats with streptozotocin-induced diabetes or galactosaemia

18 October 2022

82

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Changes in axonally transported proteins during axon regeneration in toad retinal ganglion cells

18 October 2022

83

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Growth-associated proteins and the curious dichotomies of nerve regeneration

18 October 2022

84

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Growth-associated protein, GAP-43, a polypeptide that is induced when neurons extend axons, is a component of growth cones and corresponds to pp46, a major polypeptide of a subcellular fraction enriched in growth cones

18 October 2022

85

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Polyols and myo-inositol in diabetic neuropathy--of mice and men

18 October 2022

87

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Coexistence of nerve conduction deficit with increased Na(+)-K(+)-ATPase activity in galactose-fed mice. Implications for polyol pathway and diabetic neuropathy

18 October 2022

88

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Aldose reductase inhibitors in the treatment of diabetic neuropathy. A review of the rationale and clinical evidence

18 October 2022

89

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Clinical trials with aldose reductase inhibitors

18 October 2022

90

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

A thirty year journey in the polyol pathway

18 October 2022

92

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

The effect of aldose reductase inhibition on motor nerve conduction velocity in diabetic rats

18 October 2022

93

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Effect of a new aldose reductase inhibitor, (E)-3-carboxymethyl-5-[(2E)-methyl-3-phenylpropenylidene]rhodanine (ONO-2235) on peripheral nerve disorders in streptozotocin-diabetic rats

18 October 2022

94

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Tolrestat, an aldose reductase inhibitor, prevents nerve dysfunction in conscious diabetic rats

18 October 2022

95

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Prevention and reversal of defective axonal transport and motor nerve conduction velocity in rats with experimental diabetes by treatment with the aldose reductase inhibitor Sorbinil

18 October 2022

96

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Novel, potent aldose reductase inhibitors: 3,4-dihydro-4-oxo-3-[[5-(trifluoromethyl)-2-benzothiazolyl] methyl]-1-phthalazineacetic acid (zopolrestat) and congeners

18 October 2022

97

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Characterization of a novel aldose reductase inhibitor, FR74366, and its effects on diabetic cataract and neuropathy in the rat

18 October 2022

98

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Effects of aldose reductase inhibitor sorbinil on neuroaxonal dystrophy and levels of myo-inositol and sorbitol in sympathetic autonomic ganglia of streptozocin-induced diabetic rats

18 October 2022

99

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Effects of long-term aldose reductase inhibition on development of experimental diabetic neuropathy. Ultrastructural and morphometric studies of sural nerve in streptozocin-induced diabetic rats

18 October 2022

100

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Effects of sorbinil, dietary myo-inositol supplementation, and insulin on resolution of neuroaxonal dystrophy in mesenteric nerves of streptozocin-induced diabetic rats

18 October 2022

101

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Preventive effect of long-term aldose reductase inhibition (ponalrestat) on nerve conduction and sural nerve structure in the spontaneously diabetic Bio-Breeding rat

18 October 2022

102

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Prevention of defective axonal transport in streptozocin-diabetic rats by treatment with "Statil" (ICI 128436), an aldose reductase inhibitor

18 October 2022

103

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Treatment with an aldose reductase inhibitor can reduce the susceptibility of fast axonal transport following nerve compression in the streptozotocin-diabetic rat

18 October 2022

104

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Aldose reductase inhibition improves nerve conduction velocity in diabetic patients

18 October 2022

105

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

The effect of an aldose reductase inhibitor (Sorbinil) on diabetic neuropathy and neural function of the retina: a double-blind study

18 October 2022

106

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Aldose reductase inhibition in diabetic neuropathy: clinical and neurophysiological studies of one year's treatment with sorbinil

18 October 2022

107

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Treatment of severely painful diabetic neuropathy with an aldose reductase inhibitor: relief of pain and improved somatic and autonomic nerve function

18 October 2022

108

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

A Controlled Trial of Sorbinil, an Aldose Reductase Inhibitor, in Chronic Painful Diabetic Neuropathy

18 October 2022

109

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Autonomic and peripheral nerve function in early diabetic neuropathy. Possible influence of a novel aldose reductase inhibitor on autonomic function

18 October 2022

110

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

The effect of an aldose reductase inhibitor on cardiovascular performance in patients with diabetes mellitus

18 October 2022

111

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Regeneration and repair of myelinated fibers in sural-nerve biopsy specimens from patients with diabetic neuropathy treated with sorbinil

18 October 2022

112

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Reversal of deficits in axonal transport and nerve conduction velocity by treatment of streptozotocin-diabetic rats with myo-inositol

18 October 2022

115

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Dietary myo-inositol intake and peripheral nerve function in diabetic neuropathy

18 October 2022

117

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Oral supplementation of myoinositol: effects on peripheral nerve function in human diabetics and on the concentration in plasma, erythrocytes, urine and muscle tissue in human diabetics and normals

18 October 2022

118

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

High-dose dietary myo-inositol supplementation does not alter the ischaemia phenomenon in human diabetics.

18 October 2022

120

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Critical review of gangliosides and thyrotropin-releasing hormone in peripheral neuromuscular diseases

18 October 2022

124

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Ganglioside treatment of neuropathy in diabetic mice

18 October 2022

125

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Development of diabetic neuropathy in the C57BL/Ks (db/db) mouse and its treatment with gangliosides

18 October 2022

126

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Ganglioside treatment of diabetic rats; effects on nerve adenosine triphosphatase activity and motor nerve conduction velocity

18 October 2022

127

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

ATPase activity defects in alloxan-induced diabetic sciatic nerve recovered by ganglioside treatment

18 October 2022

128

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Ganglioside treatment of streptozotocin-diabetic rats prevents defective axonal transport of 6-phosphofructokinase activity

18 October 2022

129

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Ganglioside treatment and improved axonal regeneration capacity in experimental diabetic neuropathy

18 October 2022

130

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Ganglioside treatment in diabetic peripheral neuropathy: A multicenter trial

18 October 2022

131

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Changes in thermal sensation in diabetic patients after treatment with gangliosides

18 October 2022

132

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

A new prostaglandin E1 analogue (TFC-612) improves the reduction in motor nerve conduction velocity in spontaneously diabetic GK (Goto-Kakizaki) rats.

18 October 2022

133

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

The correlation between sensory nerve conduction velocities and three metabolic indices in rats treated with streptozotocin

18 October 2022

136

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Essential fatty acid treatment--effects on nerve conduction, polyol pathway and axonal transport in streptozotocin diabetic rats

18 October 2022

138

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Essential fatty acid diet supplementation. Effects on peripheral nerve and skeletal muscle function and capillarization in streptozocin-induced diabetic rats.

18 October 2022

139

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

The effects of dietary treatment with essential fatty acids on sciatic nerve conduction and activity of the Na+/K+ pump in streptozotocin‐diabetic rats

18 October 2022

140

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking

18 October 2022

141

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Nonenzymatic glycosylation of peripheral nerve protein in diabetes mellitus

18 October 2022

142

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Excessive nonenzymatic glycosylation of peripheral and central nervous system myelin components in diabetic rats

18 October 2022

143

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Accumulation of diabetic rat peripheral nerve myelin by macrophages increases with the presence of advanced glycosylation endproducts

18 October 2022

144

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Recognition and uptake of human diabetic peripheral nerve myelin by macrophages

18 October 2022

145

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Aminoguanidine effects on nerve blood flow, vascular permeability, electrophysiology, and oxygen free radicals

18 October 2022

146

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

The thermal stability of collagen in diabetic rats: correlation with severity of diabetes and non-enzymatic glycosylation

18 October 2022

147

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Nonenzymatic glycosylation and the pathogenesis of diabetic complications

18 October 2022

148

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Non-enzymatic glycosylation and the chronic complications of diabetes: an overview

18 October 2022

149

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Nerve blood flow in early experimental diabetes in rats: relation to conduction deficits

18 October 2022

151

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes

18 October 2022

152

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Effect of Aminoguanidine on Functional and Structural Abnormalities in Peripheral Nerve of STZ-Induced Diabetic Rats

18 October 2022

154

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Can faulty vitamin B-12 (cobalamin) metabolism produce diabetic neuropathy?

18 October 2022

155

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Methylcobalamin improves nerve conduction in streptozotocin-diabetic rats without affecting sorbitol and myo-inositol contents of sciatic nerve

18 October 2022

156

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Diabetes mellitus-associated decrease in nerve growth factor levels is reversed by allogeneic pancreatic islet transplantation

18 October 2022

158

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Low serum levels of nerve growth factor in diabetic neuropathy

18 October 2022

159

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Stimulation of nerve growth factor synthesis/secretion by 1,4-benzoquinone and its derivatives in cultured mouse astroglial cells

18 October 2022

160

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

Stimulatory effect of 4-alkylcatechols and their diacetylated derivatives on the synthesis of nerve growth factor

18 October 2022

161

1 reference

https://api.crossref.org/works/10.1002/DMR.5610080107

18 October 2022

Identifiers

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1633740

18 October 2022

1 reference